Metronidazole

Product NDC
70518-3073
11-digit product format
705183073
Labeler code
70518
Product ID
70518-3073_e5ba2c59-93e8-3c1f-e053-2995a90a3bd7
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
METRONIDAZOLE
Dosage form
TABLET
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA205245
Marketing category
ANDA
Marketing start
2021-04-19
Marketing end
0000-00-00
Substance
METRONIDAZOLE
Active strength
250 mg/1
Pharmacologic classes
Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
140QMO216EMETRONIDAZOLE443-48-1METRONIDAZOLE

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-3073-07051830730030 TABLET in 1 BLISTER PACK (70518-3073-0) 30 tablet2021-04-190000-00-00NoNoCurrent
70518-3073-17051830730128 TABLET in 1 BLISTER PACK (70518-3073-1) 28 tablet2022-02-100000-00-00NoNoCurrent
70518-3073-27051830730228 TABLET in 1 BLISTER PACK (70518-3073-2) 28 tablet2022-02-100000-00-00NoNoCurrent
70518-3073-37051830730328 TABLET in 1 BLISTER PACK (70518-3073-3) 28 tablet2022-08-070000-00-00NoNoCurrent